These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23377410)

  • 1. Urinary bladder leiomyosarcoma: staging with 18F-FDG PET/CT.
    Makis W; Rakheja R; Nahal A; Hickeson M; Lisbona R
    Clin Nucl Med; 2013 May; 38(5):e218-22. PubMed ID: 23377410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare case of malignant urinary bladder paraganglioma with distant metastases demonstrated by 18F-FDG PET/CT.
    Manohar K; Mittal BR; Bhattacharya A; Kashyap R; Aggarwal MM; Mandal AK
    Clin Nucl Med; 2012 Jun; 37(6):e148-9. PubMed ID: 22614213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique.
    Nayak B; Dogra PN; Naswa N; Kumar R
    Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):386-93. PubMed ID: 23179944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare case of urachal mucinous adenocarcinoma detected by 18F-FDG PET/CT.
    Li X; Liu S; Yao S; Wang M
    Clin Nucl Med; 2015 Mar; 40(3):282-5. PubMed ID: 25608160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer.
    Mertens LS; Mir MC; Scott AM; Lee ST; Fioole-Bruining A; Vegt E; Vogel WV; Manecksha R; Bolton D; Davis ID; Horenblas S; van Rhijn BW; Lawrentschuk N
    Urology; 2014 Feb; 83(2):393-8. PubMed ID: 24468513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed imaging of the pelvis with diluted and filled bladder: a simple and efficient method in FDG PET/CT imaging of bladder carcinoma.
    Halac M; Aliyev A; Yılmaz S; Ozhan M; Kaya R; Sağer S; Ergül N
    Clin Nucl Med; 2012 Aug; 37(8):778-80. PubMed ID: 22785509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual phase 18F-fluorodeoxyglucose positron emission tomography/computed tomography with forced diuresis in diagnostic imaging evaluation of bladder cancer.
    Yildirim-Poyraz N; Ozdemir E; Uzun B; Turkolmez S
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):214-21. PubMed ID: 23218514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy.
    Rouanne M; Girma A; Neuzillet Y; Vilain D; Radulescu C; Letang N; Yonneau L; Hervé JM; Botto H; Le Stanc E; Lebret T
    Eur J Surg Oncol; 2014 Dec; 40(12):1724-30. PubMed ID: 25242381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG in Urologic Malignancies.
    Høilund-Carlsen PF; Poulsen MH; Petersen H; Hess S; Lund L
    PET Clin; 2014 Oct; 9(4):457-68, vi. PubMed ID: 26050947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy.
    Kollberg P; Almquist H; Bläckberg M; Cronberg C; Garpered S; Gudjonsson S; Kleist J; Lyttkens K; Patschan O; Liedberg F
    Scand J Urol; 2015; 49(4):296-301. PubMed ID: 25623843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG imaging of the primary breast leiomyosarcoma and follow-up lung metastasis.
    Pai M; Yoon SN
    Clin Nucl Med; 2013 Mar; 38(3):e152-4. PubMed ID: 23354027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of dual-phase (18)F-FDG PET/CT in preoperative staging of bladder cancer].
    Li H; Wu H; Wang Q; Han Y; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):500-3. PubMed ID: 24752096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
    Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P
    Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraovarian primary peritoneal carcinoma: staging with 18F-FDG PET/CT.
    Rakheja R; Makis W; Hickeson M
    Abdom Imaging; 2012 Apr; 37(2):304-8. PubMed ID: 21394599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of urine production due to renal failure enables clear visualization of primary urinary bladder carcinoma on 18F-FDG PET/CT.
    Bertagna F; Motta F; Fisogni S; Lena MS; Lucchini S; Giubbini R
    Clin Nucl Med; 2012 Jun; 37(6):611-3. PubMed ID: 22614202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET/CT of transitional cell carcinoma.
    Patil VV; Wang ZJ; Sollitto RA; Chuang KW; Konety BR; Hawkins RA; Coakley FV
    AJR Am J Roentgenol; 2009 Dec; 193(6):W497-504. PubMed ID: 19933624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early dynamic PET/CT and 18F-FDG blood flow imaging in bladder cancer detection: a novel approach.
    Belakhlef S; Church C; Jani C; Lakhanpal S
    Clin Nucl Med; 2012 Apr; 37(4):366-8. PubMed ID: 22391706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant epithelioid hemangioendothelioma of the lower extremity: staging with F-18 FDG PET/CT.
    Makis W; Ciarallo A; Nahal A; Derbekyan V
    Clin Nucl Med; 2011 Jul; 36(7):590-2. PubMed ID: 21637069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.